We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
1351
Arcus Biosciences
RCUS
$3.62B
$56.5K ﹤0.01%
2,781
RXRX icon
1352
Recursion Pharmaceuticals
RXRX
$1.7B
$56.4K ﹤0.01%
7,549
ATEN icon
1353
A10 Networks
ATEN
$1.96B
$56.4K ﹤0.01%
3,864
+312
+9% +$4.51K
SASR
1354
DELISTED
Sandy Spring Bancorp Inc
SASR
$56.4K ﹤0.01%
2,485
AMSF icon
1355
AMERISAFE
AMSF
$507M
$56.4K ﹤0.01%
1,057
WABC icon
1356
Westamerica Bancorp
WABC
$1.4B
$56.3K ﹤0.01%
1,471
SABR icon
1357
Sabre
SABR
$884M
$56.2K ﹤0.01%
+17,617
New +$63.7K
BUSE icon
1358
First Busey Corp
BUSE
$2.59B
$56.1K ﹤0.01%
2,791
IMVT icon
1359
Immunovant
IMVT
$8.57B
$56K ﹤0.01%
2,951
+585
+25% +$10.9K
PLRX icon
1360
Pliant Therapeutics
PLRX
$65.6M
$56K ﹤0.01%
+3,089
New +$73.1K
NUVL
1361
DELISTED
Nuvalent
NUVL
$55.9K ﹤0.01%
1,325
+246
+23% +$9.3K
PLL
1362
DELISTED
Piedmont Lithium
PLL
$55.5K ﹤0.01%
961
MED icon
1363
Medifast
MED
$128M
$55.4K ﹤0.01%
601
+41
+7% +$3.65K
CHGG icon
1364
Chegg
CHGG
$92.1M
$55.3K ﹤0.01%
6,228
-680
-10% -$8.25K
SAFT icon
1365
Safety Insurance
SAFT
$1.52B
$55.2K ﹤0.01%
770
CIR
1366
DELISTED
CIRCOR International, Inc
CIR
$55K ﹤0.01%
975
VRDN icon
1367
Viridian Therapeutics
VRDN
$2.46B
$54.9K ﹤0.01%
2,308
+261
+13% +$6.7K
JBSS icon
1368
John B. Sanfilippo & Son
JBSS
$1.01B
$54.9K ﹤0.01%
468
BGS icon
1369
B&G Foods
BGS
$297M
$54.4K ﹤0.01%
3,909
+388
+11% +$5.58K
CCRN
1370
DELISTED
Cross Country Healthcare
CCRN
$54.3K ﹤0.01%
1,932
FORG
1371
DELISTED
ForgeRock, Inc.
FORG
$53.7K ﹤0.01%
2,614
+303
+13% +$6.07K
UBA
1372
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$53.7K ﹤0.01%
2,524
-9
-0.4% -$168
PACW
1373
DELISTED
PacWest Bancorp
PACW
$53.7K ﹤0.01%
+6,583
New +$53.1K
NWLI
1374
DELISTED
National Western Life Group, Inc. Class A
NWLI
$53.6K ﹤0.01%
129
WRBY icon
1375
Warby Parker
WRBY
$3.13B
$53.6K ﹤0.01%
4,585

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.